Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
sustained-release matrix tablets for treatment of pneumoconiosis
a T140 analog and CXCR4 antagonist
a chemical combination of L-3,4-dihydroxyphenylalanine (L-DOPA) and gamma-aminobutyric acid (GABA)
RefSeq NM_001715
has antineoplastic activity
structure in first source
consists of pSLC-E7-Fc associated with a magnetosome-polyethylenimine gene delivery system for tumor immunotherapy
inhibits NS5A protein from hepatitis C virus; structure in first source
inhibits NS5A protein from hepatitis C virus; structure in first source
a potent and selective CCR1 antagonist; structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
a CRF1 receptor antagonist; structure in first source
a CRF1 receptor antagonist; structure in first source
a dual CCR2/CCR5 antagonist; structure in first source
an Smo inhibitor
structure in first source
for treatment of ulcerative colitis; in phase II clinical trials (2014)
structure in first source
mu receptor agonist; structure in first source
mu receptor agonist; structure in first source
prodrug of BNC105
a dry extract of five herbal drugs (Gentianae radix, Primulae flos, Rumicis herba, Sambuci flos, Vebenae herba) for treatment of acute viral rhinosinusitis
has antineoplastic activity; structure in first source
structure in first source
structure in first source
a lanatoprost prodrug, nitric oxide donor, and PGF2alpha agonist
a potent hepatitis C virus NS5A inhibitor; structure in first source
structure in first source
synthetic cyclic peptide effective against plant pathogens; linear analog is poorly active
GenBank ABL67947
expressed in Paneth cells; involved in immune response to Vibrio cholerae; RefSeq NM_033197
RefSeq NM_001012392
RefSeq NM_121905
BPP - bradykinin potentiating peptide
an aurora kinase inhibitor; structure in first source
antiviral; structure in first source
involved in pathogenicity of the organism; RefSeq YP_108169
RefSeq NM_152743
The phosphoprotein encoded by the BRCA1 gene (GENE, BRCA1). It contains an N-terminal RING FINGER DOMAIN and is a PROTEIN PHOSPHATASE 1 regulatory subunit. In normal cells the BRCA1 protein is localized in the nucleus, whereas in the majority of breast cancer cell lines and in malignant pleural effusions from breast cancer patients, it is localized mainly in the cytoplasm. (Science 1995;270(5237):713,789-91)
A large, nuclear protein, encoded by the BRCA2 gene (GENE, BRCA2). Mutations in this gene predispose humans to breast and ovarian cancer. The BRCA2 protein is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev. 2000;14(11):1400-6)
RefSeq NM_001166457
a RAD18-interacting protein; RefSeq NM_134071
STK33 kinase inhibitor; structure in first source